Kezar Life Sciences, Inc. (KZR) Short term Debt (2024 - 2025)
Kezar Life Sciences (KZR) posted Short term Debt of $5.3 million for Q3 2025, little changed sequentially from $5.3 million in Q2 2025, and up 34.91% YoY from $3.9 million in Q3 2024.
Kezar Life Sciences, Inc. (KZR) Short term Debt (2024 - 2025) Analysis & Trends
Kezar Life Sciences has reported Short term Debt for 2 years, with the latest figure at $5.3 million in Q3 2025.
- Quarterly Short term Debt rose 34.91% year-over-year to $5.3 million in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $5.3 million (up 34.91% YoY) and the FY2024 annual result came in at $5.2 million, changed N/A from the prior year.
- Short term Debt held at $5.3 million in Q3 2025 per KZR's latest filing, from $5.3 million in the prior quarter.
- Over five years, Short term Debt peaked at $5.3 million in Q2 2025 and troughed at $1.3 million in Q1 2024.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 5.28 Mn |
| Jun 30, 2025 | 5.29 Mn |
| Mar 31, 2025 | 5.22 Mn |
| Dec 31, 2024 | 5.22 Mn |
| Sep 30, 2024 | 3.91 Mn |
| Jun 30, 2024 | 2.61 Mn |
| Mar 31, 2024 | 1.30 Mn |